ARAMIS trial finds no benefit of anakinra in acute myocarditis

The largest randomized controlled trial of patients with acute myocarditis has found that anakinra is safe but does not reduce complications. The late breaking research presented in a Hot Line session today at ESC Congress 2023.

Major biomedical research funder Wellcome Trust names Røttingen as its new CEO

LONDON — The Wellcome Trust — the world’s second largest private funder of biomedical research — announced on Wednesday that Norwegian scientist and public health

October 11, 2023

Medartis 2023 half-year results presentation – Biotech Investments

Medartis Holding AG / Key word(s): Half Year Results Medartis 2023 half-year results presentation 25.07.2023 / 09:00 CET/CEST INVITATION │ AUDIO WEBCAST We are pleased

July 26, 2023

Being psychologically resilient can reduce the risk of all-cause mortality

The study highlights the protective effect of psychological resilience on mortality, indicating its significance for enhancing longevity in aging populations.

September 6, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.